Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Educational Status × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 8 Prostatic Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 3 Pancreatic Neoplasms 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Malignant Solid Neoplasm 2 Skin Carcinoma 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Ovarian Neoplasms 1 Obesity 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Erectile Dysfunction 1

Interventions

Nivolumab 22 cabozantinib 18 Magnetic Resonance Spectroscopy 16 Specimen Handling 15 Ipilimumab 11 pembrolizumab 10 Biopsy 7 Sunitinib 6 Radiosurgery 6 CTLA-4 Antigen 6 Axitinib 5 lenvatinib 4 belzutifan 4 atezolizumab 4 zimberelimab 3 palbociclib 3 avelumab 3 aldesleukin 3 tivozanib 2 pazopanib 2 olaparib 2 fludarabine 2 Oxaliplatin 2 Nephrectomy 2 Leucovorin 2 Immunoglobulin G 2 Fluorouracil 2 Disulfides 2 Cyclophosphamide 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡